We will allot and issue the Over-allotment Shares at HK$268.00 per Share (exclusive of brokerage of 1%, SFC transaction levy of 0.0027% and Hong Kong Stock Exchange trading fee of 0.005%), being the International Offer Price.
Approval of Listing
The Listing Committee of the Hong Kong Stock Exchange has granted the approval for the listing of and permission to deal in the Over-allotment Shares. Listing of and dealings in the Over-allotment Shares on the Main Board of the Hong Kong Stock Exchange will commence at 9:00 a.m. on April 28, 2021.
Our Total Number of Issued Shares upon the Full Exercise of the Over-Allotment Option
Our total number of issued Shares immediately before and immediately after the completion of the full exercise of the Over-allotment Option (assuming the total number of issued Shares remains unchanged since February 28, 2021 (after accounting for the Share Subdivision), except for the Shares issued following the completion of the Global Offering) is 632,711,112 Shares and 637,456,412 Shares, respectively.
Use of Proceeds
The gross proceeds to the Company from the Over-allotment Option, before deduction of the underwriting fees and other offering expenses payable by us in connection with the exercise of the Over-allotment Option, are expected to be approximately HK$1.27 billion. We intend to apply the additional net proceeds towards the same purposes as set out in the section headed “Use of Proceeds” in the Prospectus.
The Company will make a further announcement after the end of the stabilization period in connection with the Global Offering pursuant to Section 9(2) of the Securities and Futures (Price Stabilizing) Rules (Chapter 571W of the Laws of Hong Kong).
By order of the Board
Trip.com Group Limited
James Jianzhang Liang
Executive Chairman of the Board
Hong Kong, April 21, 2021
As at the date of this announcement, the board of directors of the Company comprises Mr. James Jianzhang Liang, Mr. Min Fan, Ms. Jane Jie Sun, Mr. Robin Yanhong Li and Mr. Dou Shen as directors, and Mr. Neil Nanpeng Shen, Mr. Qi Ji, Mr. Gabriel Li and Mr. JP Gan as independent directors.
2